Evidence map›Paper›PMID 31881989›Full record

ArticleBMC anesthesiology2019

Point-of-care versus central testing of hemoglobin during large volume blood transfusion.

Justin Herman, Brian Park, Bharat Awsare, Frances West, Denine Crittendon, Lilah Evans, Mary Harach, Julie Karp, Alexis Peedin, Marianna LaNoue and 3 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in BMC anesthesiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Justin HermanDepartment of Pulmonary and Critical Care Medicine, Thomas Jefferson University Hospital, 834 Walnut St Suite 650, Philadelphia, PA, 19107, USA.
Brian ParkDepartment of Internal Medicine, Thomas Jefferson University Hospital, 1025 Walnut St Room 805, Philadelphia, PA, 19107, USA.
Bharat AwsareDepartment of Pulmonary and Critical Care Medicine, Thomas Jefferson University Hospital, 834 Walnut St Suite 650, Philadelphia, PA, 19107, USA.
Frances WestDepartment of Pulmonary and Critical Care Medicine, Thomas Jefferson University Hospital, 834 Walnut St Suite 650, Philadelphia, PA, 19107, USA.
Denine CrittendonSchool of Population Health, Thomas Jefferson University, 901 Walnut St 10th Floor, Philadelphia, PA, 19107, USA.
Lilah EvansDepartment of Pathology, Thomas Jefferson University Hospital, 130 South 9th St Room 2109, Philadelphia, PA, 19107, USA.
Mary HarachBlood Bank and Transfusion Medicine, Thomas Jefferson University Hospital, 111 South 11th St, Philadelphia, PA, 19107, USA.
Julie KarpBlood Bank and Transfusion Medicine, Thomas Jefferson University Hospital, 111 South 11th St, Philadelphia, PA, 19107, USA.
Alexis PeedinBlood Bank and Transfusion Medicine, Thomas Jefferson University Hospital, 111 South 11th St, Philadelphia, PA, 19107, USA.
Marianna LaNoueSchool of Population Health, Thomas Jefferson University, 901 Walnut St 10th Floor, Philadelphia, PA, 19107, USA.
Barbara GoldsmithDepartment of Pathology, Thomas Jefferson University Hospital, 130 South 9th St Room 2109, Philadelphia, PA, 19107, USA.
Eugene WarnickSidney Kimmel Medical College, Thomas Jefferson University, 1025 Walnut St, Philadelphia, PA, 19107, USA.
Michael BaramDepartment of Pulmonary and Critical Care Medicine, Thomas Jefferson University Hospital, 834 Walnut St Suite 650, Philadelphia, PA, 19107, USA. michael.baram@jefferson.edu.
Thomas Jefferson University Hospital · USThomas Jefferson University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPoint-of-care (POC) hemoglobin testing has the potential to revolutionize massive transfusion strategies. No prior studies have compared POC and central laboratory testing of hemoglobin in patients undergoing massive transfusions.

methodsWe retrospectively compared the results of our point-of-care hemoglobin test (EPOC®) to our core laboratory complete blood count (CBC) hemoglobin test (Sysmex XE-5000™) in patients undergoing massive transfusion protocols (MTP) for hemorrhage. One hundred seventy paired samples from 90 patients for whom MTP was activated were collected at a single, tertiary care hospital between 10/2011 and 10/2017. Patients had both an EPOC® and CBC hemoglobin performed within 30 min of each other during the MTP. We assessed the accuracy of EPOC® hemoglobin testing using two variables: interchangeability and clinically significant differences from the CBC. The Clinical Laboratory Improvement Amendments (CLIA) proficiency testing criteria defined interchangeability for measurements. Clinically significant differences between the tests were defined by an expert panel. We examined whether these relationships changed as a function of the hemoglobin measured by the EPOC® and specific patient characteristics.

resultsFifty one percent (86 of 170) of paired samples' hemoglobin results had an absolute difference of ≤7 and 73% (124 of 170) fell within ±1 g/dL of each other. The mean difference between EPOC® and CBC hemoglobin had a bias of - 0.268 g/dL (p = 0.002). When the EPOC® hemoglobin was < 7 g/dL, 30% of the hemoglobin values were within ±7, and 57% were within ±1 g/dL. When the measured EPOC® hemoglobin was ≥7 g/dL, 55% of the EPOC® and CBC hemoglobin values were within ±7, and 76% were within ±1 g/dL. EPOC® and CBC hemoglobin values that were within ±1 g/dL varied by patient population: 77% for cardiac surgery, 58% for general surgery, and 72% for non-surgical patients.

conclusionsThe EPOC® device had minor negative bias, was not interchangeable with the CBC hemoglobin, and was less reliable when the EPOC® value was < 7 g/dL. Clinicians must consider speed versus accuracy, and should check a CBC within 30 min as confirmation when the EPOC® hemoglobin is < 7 g/dL until further prospective trials are performed in this population.

Indexed as

Point-of-Care SystemsBlood TransfusionClinical Laboratory TechniquesHemoglobinsHemorrhageHumansReproducibility of ResultsRetrospective StudiesTime FactorsHemoglobinsBleedingHemoglobinHemorrhageMassive transfusion protocolPoint-of-care lab testingTransfusion

Identifiers

PMID31881989
PMCPMC6933896
OpenAlexW2970589670

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.